CD24Fc ameliorates immune-related adverse events while preserving anti-tumor therapeutic effect.
Author
Liu, MingyueWang, Xu
Du, Xuexiang
Zhang, Yan
Ai, Chunxia
Hu-Lieskovan, Siwen
Li, Tianhong
Devenport, Martin
Liu, Yang
Zheng, Pan
Date
2022-07-15Journal
Signal Transduction and Targeted TherapyPublisher
Springer NatureType
Article
Metadata
Show full item recordIdentifier to cite or link to this item
http://hdl.handle.net/10713/19386ae974a485f413a2113503eed53cd6c53
10.1038/s41392-022-01030-x
Scopus Count
Collections
Related articles
- Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study.
- Authors: Welker J, Pulido JD, Catanzaro AT, Malvestutto CD, Li Z, Cohen JB, Whitman ED, Byrne D, Giddings OK, Lake JE, Chua JV, Li E, Chen J, Zhou X, He K, Gates D, Kaur A, Chen J, Chou HY, Devenport M, Touomou R, Kottilil S, Liu Y, Zheng P, SAC-COVID Study Team
- Issue date: 2022 May
- CD24 and Fc fusion protein protects SIVmac239-infected Chinese rhesus macaque against progression to AIDS.
- Authors: Tian RR, Zhang MX, Zhang LT, Zhang P, Ma JP, Liu M, Devenport M, Zheng P, Zhang XL, Lian XD, Ye M, Zheng HY, Pang W, Zhang GH, Zhang LG, Liu Y, Zheng YT
- Issue date: 2018 Sep
- Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis.
- Authors: Le Burel S, Champiat S, Mateus C, Marabelle A, Michot JM, Robert C, Belkhir R, Soria JC, Laghouati S, Voisin AL, Fain O, Mékinian A, Coutte L, Szwebel TA, Dunogeant L, Lioger B, Luxembourger C, Mariette X, Lambotte O
- Issue date: 2017 Sep
- Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology.
- Authors: Song NJ, Allen C, Vilgelm AE, Riesenberg BP, Weller KP, Reynolds K, Chakravarthy KB, Kumar A, Khatiwada A, Sun Z, Ma A, Chang Y, Yusuf M, Li A, Zeng C, Evans JP, Bucci D, Gunasena M, Xu M, Liyanage NPM, Bolyard C, Velegraki M, Liu SL, Ma Q, Devenport M, Liu Y, Zheng P, Malvestutto CD, Chung D, Li Z
- Issue date: 2022 Jan 10
- TREATMENT WITH SOLUBLE CD24 ATTENUATES COVID-19-ASSOCIATED SYSTEMIC IMMUNOPATHOLOGY.
- Authors: Song NJ, Allen C, Vilgelm AE, Riesenberg BP, Weller KP, Reynolds K, Chakravarthy KB, Kumar A, Khatiwada A, Sun Z, Ma A, Chang Y, Yusuf M, Li A, Zeng C, Evans JP, Bucci D, Gunasena M, Xu M, Liyanage NPM, Bolyard C, Velegraki M, Liu SL, Ma Q, Devenport M, Liu Y, Zheng P, Malvestutto CD, Chung D, Li Z
- Issue date: 2021 Sep 16